If I read it correctly - it works better than temozolomide (the SOC) for that patient group, i.e patients who are resistant to temozolomide. Not patients temozolomide does work in. More than happy to be corrected.
Ann: Kazia releases final data from P2 paxalisib trial, page-12
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)